The three-dimensional organization of chromatin within the nucleus is a key facet of epigenetic control of gene expression and genome stability.[@R1]^-^[@R3] One such organizational feature is the positioning of heterochromatin domains derived from different chromosomes within a compartment at the inner periphery of eukaryotic nuclei.[@R3]^-^[@R10] This peripheral heterochromatin compartment is attached to the nuclear envelope and houses epigenetically silent genes and gene-poor DNA. There is evidence that the attachment of genes to the nuclear periphery promotes epigenetic gene silencing in both engineered and biological settings.[@R7]^,^[@R11] The peripheral heterochromatin compartment is visualized as associating with the nuclear envelope, but the nature, breadth, and redundancies of the biochemical attachment mechanisms remain to be fully revealed. How these attachments might be faithfully restored during cell division is also largely unknown.

In metazoan cells, the peripheral heterochromatin compartment attaches to the nuclear lamina, the protein framework that lies under the inner nuclear membrane. The nuclear lamina is a meshwork composed of intermediate filament proteins, the A- and B-type lamins: Lamin A/C, Lamin B1, and Lamin B2.[@R12]^-^[@R14] Important biological roles for the nuclear lamina as a docking site for peripheral heterochromatin continue to emerge within many normal and disease processes, including development,[@R11] cancer,[@R15]^,^[@R16] aging,[@R17] and cell senescence.[@R18]^-^[@R20] In diseases of the nuclear lamina, the laminopathies,[@R13]^,^[@R21]^-^[@R23] as well as in cancer, nuclear deformities are observed.[@R16] There are several non-mutually exclusive models regarding how these nuclear defects may contribute to disease, including effects on gene expression.[@R16] In particular, it will be important to explore nuclear lamina-chromatin attachment mechanisms in normal and diseased cells, as differential interactions may affect gene expression and thereby underlie disease phenotypes.[@R24] In view of the broad biological impact of nuclear lamina-heterochromatin attachment, it will be critical to obtain a comprehensive view of the attachment mechanisms.

There are several known mechanisms by which heterochromatin, or generic chromatin, can attach to the nuclear lamina ([Fig. 1](#F1){ref-type="fig"}, top). A group of inner nuclear membrane proteins that serve to anchor the nuclear lamina also participate in chromatin attachment through BAF, a chromatin-binding adaptor protein.[@R25] The Lamin B receptor (LBR), a multifunctional inner nuclear membrane protein, binds the Lamin B component of the lamina and also attaches to heterochromatin.[@R26] Recent studies have identified a mechanism through which the transcription factor ThPOK attaches DNA to the nuclear periphery through GAGA-enriched DNA sequences.[@R27] Collectively, these attachment modes have been referred to as "tethering," indicating a direct or indirect linking of chromatin to the nuclear lamina. An emerging theme in the literature is that there are likely redundancies and specialization of tethering mechanisms.

![**Figure 1.** Top: Interphase diagram showing known chromatin-nuclear envelope tethering mechanisms, along with the role proposed for PRR14. Model depicts PRR14 as a non-membrane protein, tethering between Lamin A/C and heterochromatin-bound HP1. Bottom: Telophase model depicting a role for PRR14 in specifying heterochromatin destined for reassembly at the nuclear lamina at mitotic exit. Telophase model is based on the dynamic behavior of tagged PRR14.](nucl-5-32-g1){#F1}

An important achievement in this field was the development of methods to map DNA sequences in close contact with the nuclear lamina, lamina associated domains (LADs).[@R28]^,^[@R29] Such studies have used both DNA modification (DamID)[@R28] and chromatin immunoprecipitation (ChIP) methods.[@R3]^,^[@R19]^,^[@R20]^,^[@R30]^,^[@R31] LAD mapping has allowed integration of LAD sequences with epigenome-wide features such as DNA methylation, histone modifications, and gene-specific transcriptional states. Remarkably, the LADs (0.1--10 Mb in length) have been found to constitute 35--40% of nuclear DNA. It appears that LADs represent epigenetically silent or gene-poor regions, and largely correspond to the peripheral heterochromatin compartment that can be visualized microscopically ([Fig. 2](#F2){ref-type="fig"}).

![**Figure 2.** Confocal imaging showing localization of GFP-tagged PRR14 at the nuclear lamina and the peripheral heterochromatin compartment as detected by anti-H3K9me3 staining.](nucl-5-32-g2){#F2}

The repressive histone 3 lysine 9 di-, tri-methylation (H3K9me2/3) modification, a hallmark of epigenetically silent gene promoters and heterochromatin domains, is enriched at the inner nuclear periphery ([Fig. 2](#F2){ref-type="fig"}).[@R10] The role, and maintenance, of H3K9 methylation at the nuclear periphery has recently been reviewed and we refer the reader to these excellent articles.[@R3]^,^[@R32]^,^[@R33] Recent work has indicated that H3K9 methylation is important for positioning of peripheral heterochromatin.[@R9]^,^[@R34] Furthermore, H3K9me2/3-marked heterochromatin has been found to coincide with LADs,[@R34]^-^[@R36] and the histone methyltransferase G9a that places the H3K9me2 mark was found to regulate contact of LADs with the nuclear lamina.[@R34] As H3K9 methylation appears to be important in positioning of peripheral heterochromatin, it might be expected that multiple tethering mechanisms utilize this modification. Early studies showed that the LBR tether binds to heterochromatin protein 1 (HP1), an H3K9me2/3 binding protein.[@R26]^,^[@R37] Our recent study[@R38] detected a new HP1-H3K9me3-dependent tether, as summarized below.

We identified a previously unstudied human protein, Proline Rich 14 (PRR14), during a genome-wide siRNA screen for epigenetic silencing factors (manuscript in preparation). The screening system utilizes reporter cells harboring chromosomally dispersed, epigenetically silent GFP transgenes that become reactivated in response to siRNA-based knockdown of epigenetic silencing factors.[@R39] The system was designed to be capable of detecting factors that have broad, rather than gene-specific roles in epigenetic silencing. The PRR14 gene is widely expressed and predicted to encode a 585 amino acid proline-rich protein. Bioinformatic analyses indicated that PRR14 lacks any identifiable functional domains.[@R38] We found that PRR14 localizes to the nuclear lamina in human interphase cells ([Fig. 2](#F2){ref-type="fig"}), and its depletion results in cellular phenotypes reminiscent of laminopathies, including distorted nuclei ([Fig. 3](#F3){ref-type="fig"}).[@R38] The mechanisms underlying the defects have not been fully investigated. We speculate that PRR14 may play a role in maintenance of the nuclear lamina or could also serve as part of a platform for reassembly of the nuclear lamina at mitotic exit. Notably, PRR14 has not been detected in protein-protein interaction studies using nuclear lamina or nuclear envelope components as bait[@R25]^,^[@R40]^,^[@R41] but has been detected in other protein-protein interaction screens (see below).

![**Figure 3.** Confocal imaging showing nuclear lamina defects after PRR14 knockdown. Cells were transfected with the indicated siRNAs and monitored by confocal imaging 72h post-transfection. Scale bars, 10 μm.](nucl-5-32-g3){#F3}

Although full-length PRR14 localizes to the nuclear lamina, we found that the PRR14 N-terminal fragment colocalized with H3K9me3-marked heterochromatin throughout the nucleus.[@R38] This finding suggested that PRR14 was also a heterochromatin binding protein and could thereby function as a tether to mediate attachment of heterochromatin to the nuclear lamina. PRR14 had been identified as an HP1 binding partner in two independent protein-protein interaction screens,[@R42]^,^[@R43] providing a mechanism by which PRR14 might bind heterochromatin. HP1 binds to histone H3K9me2/3 modifications on heterochromatin via its N-terminal chromodomain (CD), while the C-terminal chromoshadow domain (CSD) facilitates homo- and hetero-dimerization of HP1 family members HP1α, HP1β, and HP1γ.[@R44] HP1 functions as an adaptor protein to recruit binding partners that provide a repressive readout of H3K9 methyl marks. These HP1 binding partners frequently encode PxVxL motifs that interact with a pocket formed by dimerization of the HP1 CSDs.[@R45] HP1 proteins positioned on H3K9me2/3-marked heterochromatin thereby provide an extended platform for binding of effector proteins via the CSDs. In one of the aforementioned protein-protein interaction studies, PRR14 was detected as associating with HP1α dimers through the CSD PxVxL binding pocket.[@R42] Consistent with this study, we found that the PRR14 N-terminal fragment colocalized with HP1, and this binding was dependent on a PRR14 LAVVL motif, a variant of canonical PxVxL HP1-binding motif.[@R38] These findings provided a more detailed mechanism through which nuclear lamina-associated PRR14 could attach to, and possibly tether, heterochromatin. A role for PRR14 as a functional heterochromatin-nuclear lamina tether was supported by PRR14 siRNA-based knockdown experiments, which resulted in partial disruption of peripheral H3K9me3-marked heterochromatin.[@R38]

As mentioned, LBR is also an HP1-binding nuclear lamina tether but, in apparent contrast to PRR14, its localization is membrane dependent. As we found that localization of PRR14 at the nuclear lamina required Lamina A/C, we hypothesized that PRR14 may attach heterochromatin to the nuclear lamina through Lamin A/C. Recent work has distinguished so-called "Lamin A/C-dependent" and "LBR-dependent" tethering mechanisms.[@R46] We found that, in HeLa cells, siRNA-based knockdown of LBR alone had no effect on the peripheral heterochromatin compartment, indicating the existence of redundant mechanisms.[@R38] However, knockdown of PRR14 produced significant disassociation of peripheral heterochromatin as compared with single knockdown of either Lamin A/C or LBR. As the effect of PRR14 knockdown on peripheral heterochromatin could only be reproduced by double knockdown of LBR and Lamin A/C, the tethering role of PRR14 may extend beyond attaching heterochromatin to Lamin A/C. We hypothesized that the more dramatic PRR14 knockdown phenotype might indicate a second, essential function for PRR14 during mitosis, as summarized below.[@R38]

The proposal that PRR14 functions as a tether for peripheral heterochromatin suggested that its disassembly and reassembly during mitosis would be highly regulated. Indeed, the dynamic behavior of PRR14 during cell division indicated that it may serve to specify H3K9me3-HP1-marked heterochromatin for proper assembly at the nuclear lamina as cells exit mitosis, as follows ([Fig. 1](#F1){ref-type="fig"}, bottom). Our working model[@R38] encompasses the known mitotic behaviors of the HP1 protein and its ligand, the H3K9me2/3 modification.[@R47]^,^[@R48] HP1 is bound to H3K9me2/3 in interphase to facilitate numerous processes, including heterochromatin-nuclear lamina tethering. In prophase, HP1 is ejected from H3K9me2/3 modifications through Aurora B kinase-mediated phosphorylation of the neighboring H3 serine 10 residue (H3S10P).[@R49] After ejection of HP1, the H3K9me2/3 modification is retained throughout mitosis as a stable chromatin mark.[@R48] During prophase and prometaphase, PRR14 is released from the nuclear lamina and appears to be largely excluded from chromatin.[@R38] Strikingly, PRR14 remains dispersed during metaphase, similar to the known and observed mitotic behavior of HP1 ([Fig. 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}; [Videos 2 and 3](#SUP1){ref-type="supplementary-material"}).

![**Figure 4.** Further evidence for HP1-dependent localization of PRR14 on chromatin. For these experiments, HeLa cells stably expressing both GFP-PRR14 and RFP-HP1α were used. Left: Cells were treated with the indicated drugs for 3h, and images were acquired using confocal microscopy. Mock indicates untreated cells progressing to metaphase. Aurora B kinase inhibitor ZM447439 treatment resulted in prometaphase arrest and co-retention of PRR14 and HP1 on chromatin. Right: Cells were transfected with indicated siRNAs 72h prior to drug treatment. Cells were then treated with both nocodazole and ZM447439 for 3 h, and confocal images were acquired. As shown, only knockdown of all three HP1 isoforms resulted in PRR14 release from chromatin.](nucl-5-32-g4){#F4}

![**Figure 5.** Snapshots from the 3D-renderings generated by Imaris software, showing localization of Lamin A/C, GFP-PRR14, and DAPI (DNA) in HeLa cells at various stages of mitosis. [Videos 1--5](#SUP1){ref-type="supplementary-material"} of 3D renderings correspond to interphase, prophase, prometaphase, anaphase, and telophase stages, respectively. The interphase nucleus shown was chosen to highlight the localization of PRR14 with nuclear channels.](nucl-5-32-g5){#F5}

To further investigate the mechanisms underlying PRR14 dynamics in early mitosis, we devised the following experiment ([Fig. 4](#F4){ref-type="fig"}). Cells expressing GFP-tagged PRR14 and RFP-tagged HP1 were arrested in prometaphase using nocodazole, and, as expected, PRR14 and HP1 were largely absent from prometaphase chromatin. To test whether this pattern was related to ejection of HP1 though activity of Aurora B kinase, cells were treated with the Aurora B kinase inhibitor ZM447439. This treatment revealed binding of both PRR14 and HP1 to prometaphase chromatin. This co-retention of PRR14 and HP1 is consistent with our other finding that PRR14 binding to chromatin is HP1-dependent.[@R38] This experimental design also allowed us to address which HP1 isoforms (HP1α, HP1β, or HP1γ) are required for PRR14 chromatin binding. HP1 isoform knockdown was performed, followed by treatment with nocodazole plus ZM447439. Similar to our results with interphase cells,[@R38] knockdown of all three HP1 isoforms was required for PRR14 release from chromatin. Our work supports the role of PRR14 as a binding partner of HP1,[@R42] and it will be of interest to understand how HP1 isoforms or heterodimers contribute to PRR14 function.

After release of PRR14 from chromatin in early mitosis, PRR14 rapidly relocalizes to chromosomes at the onset of anaphase. PRR14 and HP1 were found to colocalize on anaphase chromosomes and such PRR14 binding required the PRR14 N-terminal HP1-binding motif.[@R38] Thus, anaphase chromatin binding of PRR14 appears to be HP1-dependent and likely corresponds with the H3S10P dephosphorylation that begins in anaphase to allow rebinding of HP1 to the mitotically stable H3K9me2/3 marks. These findings provide support for two mechanistically separable steps of PRR14 reassembly as a tether: a "specification step" whereby PRR14 binds to H3K9me3 on anaphase chromosomes via HP1 and an "association step" whereby PRR14 may track with H3K9me3-HP1-marked heterochromatin to the reassembling nuclear lamina at mitotic exit ([Fig. 1](#F1){ref-type="fig"}, bottom). If this interpretation is correct, PRR14 may serve a "bookmarking" function[@R50] to restore peripheral heterochromatin by guiding it to the nuclear lamina. The behavior of PRR14 throughout mitosis indicates that it is well suited to carry out this role, as it appears to remain soluble. This is in contrast to the BAF and LBR chromatin/heterochromatin binding proteins, which have membrane-associated functions during late mitosis ([Fig. 1](#F1){ref-type="fig"}).[@R26]^,^[@R51]^,^[@R52] As opposed to the membrane-associated LBR heterochromatin binding protein, PRR14 assembles deep into chromosomes at the onset of anaphase. We speculate that the soluble nature of PRR14 allows the penetration of anaphase chromosomes for specification of HP1-bound heterochromatin. 3D-renderings of GFP-tagged PRR14 bound to anaphase chromosomes demonstrate such chromatin association ([Fig. 5](#F5){ref-type="fig"}; [Video S4](#SUP1){ref-type="supplementary-material"}).

A recent study used chromosome conformation capture methods to determine the three dimensional chromatin-folding states of metaphase chromosomes.[@R53] While interphase chromatin organization is locus-specific in different cell types, metaphase chromatin organization was found to be cell-type- and locus-independent; the topological associating domains (TADs) found in interphase were replaced with a linear chromatin organizational pattern. The rapid binding of PRR14 at the metaphase-anaphase transition may thereby reflect a very fundamental bookmarking role during the chromatin reorganization process from metaphase to interphase states.

Regarding a possible role for PRR14 in reassembly of peripheral heterochromatin, tracking of PRR14 and Lamin A/C during early telophase indicates that PRR14 is chromosome-associated at the time that the nuclear lamina begins to form, and only by late-telophase does PRR14 associate with the nuclear lamina ([Fig. 1](#F1){ref-type="fig"} and [5](#F5){ref-type="fig"}). Here we provide detailed 3D renderings of this step ([Fig. 5](#F5){ref-type="fig"}; [Video 5](#SUP1){ref-type="supplementary-material"}). We note that our speculation and models regarding the mitotic functions of PRR14 are based largely on the dynamic behavior of tagged PRR14 proteins. Confirmation of this role will obviously require detailed functional studies.

The PRR14 gene appears to be conserved in mammals and is widely expressed in mammalian tissues, as well as early mouse development.[@R54]^,^[@R55] The human paralogous gene, PRR14L, encodes a predicted protein of 2151 amino acids. This paralog is defined largely by strong amino acid homology within a segment near the C-termini. Interestingly, both PRR14 and PRR14L proteins were detected in proteomic studies designed to identify binding partners for the phosphatase PP2A.[@R56] This study also detected LEM-4 (ANKLE2) as a PP2A interactor. LEM-4 is a nuclear lamina-binding inner nuclear membrane protein that plays a role in PP2A recruitment for phosphoregulation of BAF.[@R57]^,^[@R58] These findings place PRR14 as a PP2A interactor at the nuclear lamina. The assembly and disassembly of PRR14 are likely regulated by phosphorylation, consistent with this PP2A association.

During the course of our work we observed that, in addition to localization to the nuclear lamina in interphase, GFP tagged-PRR14 surrounds intranuclear channels ([Fig. 5](#F5){ref-type="fig"}; [Video 1](#SUP1){ref-type="supplementary-material"}). Such channels have been reported to share components with the nuclear lamina, including A- and B-type lamins.[@R59]^,^[@R60] As reported,[@R60] we found that these channels are also associated with heterochromatin. Thus, PRR14 may also participate in tethering heterochromatin to such internal structures in addition to the peripheral nuclear lamina.[@R3]

We know very little about the PRR14 protein and many fundamental questions remain regarding its functional importance. The high proline content suggests that it may form a disordered, extended structure, with the predicted folded N-terminal region attaching to HP1-marked heterochromatin.[@R38] An extended structure may fit with a role as being tightly associated with the filamentous nuclear lamina or other nucleoskeletal components. PRR14 also has a highly basic isoelectric point and is relatively arginine-serine-rich. Whether these features reflect a direct bivalent tethering mechanism, or if PRR14 is part of a more extensive complex remains to be determined. Another fundamental question relates to the nature of the heterochromatin that may be bound by PRR14 through HP1 at the nuclear periphery. Is it comprised of genes, gene promoters, or gene-poor sequences? Lastly, the behavior of PRR14 during mitosis implicates a possible role in HP1-dependent "bookmarking" of heterochromatin for return to the nuclear lamina. Although reshuffling of LADs during cell division has been reported,[@R34] it has been argued that faithful post-mitotic restoration of peripheral heterochromatin is a fundamental process.[@R3] But how might heterochromatin that is destined for the nuclear periphery at mitotic exit be selected among the collective heterochromatin? Might HP1 isoforms be involved in such specificity?

Using a functional screen, we detected a role in epigenetic gene silencing for the human PRR14 protein. From our initial study, PRR14 appears to participate in several static and dynamic processes, from heterochromatin tethering to nuclear lamina structure. Confirmation of some of these roles will require additional rigorous experimentation. Furthermore, there have been no biological functions described for PRR14 as yet, in health or disease. As knockdown of PRR14 causes misshapen nuclei as seen in cancer and laminopathies, it will be of interest to investigate possible disease connections and develop genetic models.

Supplementary Material
======================

No potential conflict of interest was disclosed.

This work was supported in whole or in part by National Institutes of Health grants Roadmap Epigenomics DK082498 (R.A.K.), CA071515, and CA006927. This project is also funded in part, under a grant with the Pennsylvania Department of Health. The Department specifically disclaims responsibility for any analyses, interpretations, or conclusions. This work was also supported by the Fox Chase Cancer Center Keystone Program in Epigenetics and Progenitor Cells. A.P. is a recipient of an AACR Centennial Predoctoral Fellowship in Cancer Research. We thank Fabrice Roegiers and Hong Yen for critical comments and Marie Estes for assistance in preparing this manuscript. We also thank Martijn Luijsterburg for providing the mRFP-HP1α expression plasmid. The Fox Chase Cancer Center Bioimaging and Cell Sorting Facilities supported this work. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute or any other sponsoring organization.

Previously published online: [www.landesbioscience.com/journals/nucleus/article/28167](http://www.landesbioscience.com/journals/nucleus/article/28167/)

PoleshkoAMansfieldKMBurlingameCCAndrakeMDShahNRKatzRA The human protein PRR14 tethers heterochromatin to the nuclear lamina during interphase and mitotic exit Cell Rep 2013 5 292 301 10.1016/j.celrep.2013.09.024

[10.4161/nucl.28167](10.4161/nucl.28167)
